publication date: Aug. 4, 2015

Study: Robotic Surgery Shows Long-term Results Similar to Traditional Open Surgery in Bladder Cancer


In the largest multi-institutional study to date, patients diagnosed with bladder cancer and treated with robot-assisted surgery experienced similar results to those who underwent a traditional open operation, according to research led by scientists at Roswell Park Cancer Institute.

The study is a retrospective review of long-term patient outcomes for cystectomies that currently populate the International Robotic Cystectomy Consortium, which represents 11 institutions in 6 countries. Data from 702 patients with clinically localized bladder cancer from 2003 to date were analyzed for five-year recurrence-free survival (67%), cancer-specific survival (75%) and overall survival (50%). When compared with traditional open surgery, patients treated with robot-assisted surgery experienced similar long-term survival outcomes.

The study results were published in the journal of the European Association of Urology.

“We found that robot-assisted radical cystectomy, an advanced surgical procedure used to treat bladder cancer that has spread to the bladder wall or recurred, despite local treatment in the bladder, provides similar early oncological outcomes while reducing operative blood loss,” says Khurshid Guru, director of robotic surgery in the Department of Urology at RPCI.

This research was conducted in collaboration with City of Hope and Beckman Research Institute; Henry Ford Health System; Karolinska University Hospital, Stockholm; Weill Cornell Medical College; Guy’s and St Thomas’s Hospital, London; Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium; Arthur Smith Institute for Urology; University Clinics of Saarland, Homburg, Germany; Cleveland Clinic Foundation; Yonsei University Health Systems Severance Hospital, Seoul, South Korea.

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.